Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PCID2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NANS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDIA4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRKD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VPS13C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC102724984 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EID1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VTI1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SUPT20H - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF1AD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DLG3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TGFA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC1A4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZWILCH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB11A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ST6GALNAC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DUT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
THEMIS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELOVL5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on